These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 27494325)

  • 1. Contribution of dot-blot assay to the diagnosis and management of myositis: a three-year practice at a university hospital centre.
    Martel C; Vignaud G; Liozon E; Magy L; Gallouedec G; Ly K; Bezanahary H; Cypierre A; Lapébie FX; Palat S; Gondran G; Jauberteau MO; Fauchais AL
    Clin Exp Rheumatol; 2016; 34(5):918-924. PubMed ID: 27494325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.
    Srivastava P; Dwivedi S; Misra R
    Rheumatol Int; 2016 Jul; 36(7):935-43. PubMed ID: 27193471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies.
    Rönnelid J; Barbasso Helmers S; Storfors H; Grip K; Rönnblom L; Franck-Larsson K; Nordmark G; Lundberg IE
    Autoimmun Rev; 2009 Sep; 9(1):58-61. PubMed ID: 19285154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myositis specific and myositis associated autoantibodies in idiopathic inflammatory myopathies: a serologic study of 46 patients].
    Ghirardello A; Zampieri S; Iaccarino L; Tarricone E; Tonello M; Bendo R; Rondinone R; Cozzi F; Doria A
    Reumatismo; 2005; 57(1):22-8. PubMed ID: 15776143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TEST performance of a myositis panel in a clinical immunology laboratory in New South Wales, Australia.
    Tan TC; Wienholt L; Adelstein S
    Int J Rheum Dis; 2016 Oct; 19(10):996-1001. PubMed ID: 26621603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous clinical spectrum of anti-SRP myositis and importance of the methods of detection of anti-SRP autoantibodies: a multicentric study.
    Picard C; Vincent T; Lega JC; Hue S; Fortenfant F; Lakomy D; Humbel RL; Goetz J; Molinari N; Bardin N; Bertin D; Johanet C; Chretien P; Dubucquoi S; Streichenberger N; Desplat-Jégo S; Bossuyt X; Sibilia J; Abreu I; Chevailler A; Fabien N
    Immunol Res; 2016 Jun; 64(3):677-86. PubMed ID: 26744256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical contribution of myositis-related antibodies detected by immunoblot to idiopathic inflammatory myositis: A one-year retrospective study.
    Lecouffe-Desprets M; Hémont C; Néel A; Toquet C; Masseau A; Hamidou M; Josien R; Martin JC
    Autoimmunity; 2018 Mar; 51(2):89-95. PubMed ID: 29463118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients.
    Troyanov Y; Targoff IN; Tremblay JL; Goulet JR; Raymond Y; Senécal JL
    Medicine (Baltimore); 2005 Jul; 84(4):231-249. PubMed ID: 16010208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies.
    Hengstman GJ; Brouwer R; Egberts WT; Seelig HP; Jongen PJ; van Venrooij WJ; van Engelen BG
    J Neurol; 2002 Jan; 249(1):69-75. PubMed ID: 11954871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequencies and clinical associations of myositis-related antibodies in The Netherlands: A one-year survey of all Dutch patients.
    Platteel ACM; Wevers BA; Lim J; Bakker JA; Bontkes HJ; Curvers J; Damoiseaux J; Heron M; de Kort G; Limper M; van Lochem EG; Mulder AHL; Saris CGJ; van der Valk H; van der Kooi AJ; van Leeuwen EMM; Veltkamp M; Schreurs MWJ; Meek B; Hamann D
    J Transl Autoimmun; 2019 Dec; 2():100013. PubMed ID: 32743501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the diagnostic utility of new line immunoassays for myositis antibodies in clinical practice: a retrospective study.
    Montagnese F; Babačić H; Eichhorn P; Schoser B
    J Neurol; 2019 Jun; 266(6):1358-1366. PubMed ID: 30840145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of autoantibody screening in patients with autoimmune myositis.
    Ghirardello A; Zampieri S; Tarricone E; Iaccarino L; Bendo R; Briani C; Rondinone R; Sarzi-Puttini P; Todesco S; Doria A
    Autoimmunity; 2006 May; 39(3):217-21. PubMed ID: 16769655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [How can we diagnose and better understand inflammatory myopathies? The usefulness of auto-antibodies].
    Sibilia J; Chatelus E; Meyer A; Gottenberg JE; Sordet C; Goetz J
    Presse Med; 2010 Oct; 39(10):1010-25. PubMed ID: 20655695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myositis autoantibody profiles and their clinical associations in Greek patients with inflammatory myopathies.
    Zampeli E; Venetsanopoulou A; Argyropoulou OD; Mavragani CP; Tektonidou MG; Vlachoyiannopoulos PG; Tzioufas AG; Skopouli FN; Moutsopoulos HM
    Clin Rheumatol; 2019 Jan; 38(1):125-132. PubMed ID: 30145635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of myositis-specific antibodies detected on myositis line immunoassay to diagnose and sub-classify patients with suspected idiopathic inflammatory myopathy, a retrospective records-based review.
    Beaton TJ; Gillis D; Prain K; Morwood K; Anderson J; Goddard J; Baird T
    Int J Rheum Dis; 2021 Sep; 24(9):1167-1175. PubMed ID: 34250724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequencies and co-existing of myositis-specific autoantibodies in patients with idiopathic inflammatory myopathies overlapped to rheumatoid arthritis.
    Nakajima A; Yoshino K; Soejima M; Kawaguchi Y; Satoh T; Kuwana M; Yamanaka H
    Rheumatol Int; 2012 Jul; 32(7):2057-61. PubMed ID: 21479881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical phenotype of patients positive for antibodies to myositis and myositis-related disorders.
    Gofrit SG; Yonath H; Lidar M; Shoenfeld Y; Kivity S
    Clin Rheumatol; 2018 May; 37(5):1257-1263. PubMed ID: 29453582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of clinicoserologic and pathologic classifications of inflammatory myopathies: study of 178 cases and guidelines for diagnosis.
    Fernandez C; Bardin N; De Paula AM; Salort-Campana E; Benyamine A; Franques J; Schleinitz N; Weiller PJ; Pouget J; Pellissier JF; Figarella-Branger D
    Medicine (Baltimore); 2013 Jan; 92(1):15-24. PubMed ID: 23269233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies.
    Cavazzana I; Richards M; Bentow C; Seaman A; Fredi M; Giudizi MG; Palterer B; Pratesi F; Migliorini P; Franceschini F; Satoh M; Ceribelli A; Mahler M
    J Immunol Methods; 2019 Nov; 474():112661. PubMed ID: 31442464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Myositis Autoantibodies by Multi-Analytic Immunoassays in a Large Multicenter Cohort of Patients with Definite Idiopathic Inflammatory Myopathies.
    Ghirardello A; Gatto M; Franco C; Zanatta E; Padoan R; Ienna L; Gallo N; Zen M; Lundberg IE; Mahler M; Doria A; Iaccarino L
    Diagnostics (Basel); 2023 Sep; 13(19):. PubMed ID: 37835823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.